Nirvana Life Sciences Inc. filed its Annual on Aug 29, 2022 for the period ending Apr 30, 2022. In this report its auditor, Dale Matheson Carr-Hilton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -20.00% | -.--% | +100.00% |
1st Jan change | Capi. | |
---|---|---|
+100.00% | 1.41M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- NIRV Stock
- News Nirvana Life Sciences Inc.
- Nirvana Life Sciences Inc. Auditor Raises 'Going Concern' Doubt